MRNA Today - Jul 15: Moderna Sees Slight Dip
カートのアイテムが多すぎます
ご購入は五十タイトルがカートに入っている場合のみです。
カートに追加できませんでした。
しばらく経ってから再度お試しください。
ウィッシュリストに追加できませんでした。
しばらく経ってから再度お試しください。
ほしい物リストの削除に失敗しました。
しばらく経ってから再度お試しください。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
MRNA Today - Jul 15: Moderna Sees Slight Dip
-
ナレーター：
-
著者：
So, here’s what went down. The stock wasn't really vibing with the market today. It got smoked worse than the overall market averages. Volume was way lighter than usual too, which usually means folks are kinda sitting on their hands instead of jumping in. You know, that classic slow bleed vibe.
Now, why did this happen? Well, it seems like there’s a mix of stuff going on. For one, the CDC isn’t publishing that report on COVID-19 vaccine effectiveness. That’s a big deal for a company like Moderna, which has been riding the vaccine wave. When news like that drops, it can make investors a bit jittery, and they start hitting that sell button fast.
Also, there was some chatter about the Affordable Care Act subsidies set to expire soon. This could impact healthcare stocks, including Moderna, since it might affect how people access vaccines and treatments down the line.
On a brighter note, there was some buzz about Moderna’s early-stage research on a Hantavirus vaccine. That’s exciting stuff! Investors love to hear about new projects, especially in the vaccine space. But, honestly, the excitement didn’t translate to the stock today.
And just to throw something out there, Moderna’s been mentioned as one of the vaccine stocks to keep an eye on for 2026. That could mean potential upside in the future if they hit it big with new products.
So, yeah, it was a bit of a bummer day for Moderna. But that’s how the market rolls sometimes. Remember, this is just for fun and info, not financial advice. Keep doing your thing, and I’ll catch you later!
adbl_web_anon_alc_button_suppression_t1
まだレビューはありません